Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Lei Deng, Lesli A. Kiedrowski, Elizabeth Ravera, Haiying Cheng, Balazs Halmos

Research output: Contribution to journalLetter

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)e169-e172
JournalJournal of Thoracic Oncology
Volume13
Issue number9
DOIs
StatePublished - Sep 1 2018

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this